Role of Paraoxonases (PONs) in Modulating Cadmium, Manganese and Organophosphate Neurotoxicity

$254,950P42FY2015ESNIH

University Of Washington, Seattle WA

Investigators

Linked publications, trials & patents

Paper 38579196 Paper 37856511 Paper 37298071 Paper 37268114 Paper 37194087 Paper 37146172 Paper 37127223 Paper 36629036 Paper 36056313 Paper 34912029 Paper 34370398 Paper 34216730 Paper 34056147 Paper 33737076 Paper 33736365 Paper 33484495 Paper 33327933 Paper 33039505 Paper 32472844 Paper 32165138 Paper 31858786 Paper 31741542 Paper 31348423 Paper 31271426 Paper 31269057 Paper 30668980 Paper 30561876 Paper 30547568 Paper 30292653 Paper 30097475 Paper 29996457 Paper 29890505 Paper 29678176 Paper 29655037 Paper 29523932 Paper 29471284 Paper 29228398 Paper 29117434 Paper 29029324 Paper 28889264 Paper 28764109 Paper 28694016 Paper 28668760 Paper 28463420 Paper 28434990 Paper 28417440 Paper 28274800 Paper 28212397 Paper 28163110 Paper 28031394 Paper 27865893 Paper 27862095 Paper 27621283 Paper 27543421 Paper 27470083 Paper 27325068 Paper 27238723 Paper 27062895 Paper 26907702 Paper 26904161 Paper 26626702 Paper 26610921 Paper 26494550 Paper 26442452 Paper 26412077 Paper 26260986 Paper 26228081 Paper 26150248 Paper 26147526 Paper 26092916 Paper 26070339 Paper 26009633 Paper 25912463 Paper 25723336 Paper 25701811 Paper 25697678 Paper 25659769 Paper 25637461 Paper 25634431 Paper 25596881 Paper 25556233 Paper 25482923 Paper 25460623 Paper 25412286 Paper 25333274 Paper 25261454 Paper 25255692 Paper 25189163 Paper 25109824 Paper 25070982 Paper 24997849 Paper 24992516 Paper 24865645 Paper 24856650 Paper 24853996 Paper 24799192 Paper 24625392 Paper 24593143 Paper 24574147 Patent 5874291

Abstract

Summary/Abstract Project 3 consists of four specific aims all involved in understanding the role of paraoxonases 1 and 2 (PON1 and PON2) in modulating oxidative stress-induced neurotoxicity. Aim 1 will examine the role of PON1 status in modulating exposure to organophosphorus (OP) insecticides by utilizing a new biomarker, adducts to red blood cell acylpeptide hydrolase (RBC APH). It is expected that individuals with the capability for high rates of OP detoxication will exhibit lower levels of modification of the active site serine of RBC APH, as assessed by mass spectrometry. Aim 2 will examine the modifications of mouse paraoxonase 1 (MoPON1) resulting from exposures to manganese (Mn) and cadmium (Cd). A sub-aim of Aim 2 will explore the fate and function of recombinant mouse PON2 (rMoPON2) injected into PON2-/- mice which are less able to modulate oxidative stress. PON2 appears to protect PON1 from the effects of oxidative stress. This aim is based on a recent finding that under conditions of oxidative stress, the catalytic domain of PON2 is found on the outside of cells where it protects the membrane lipids from oxidation. Aim 3 will examine the modulation of PON2 levels by estrogens and dopamine in the CNS and the role of microglial PON2 in the neuroprotective effects of estrogens. The structure of a higher molecular weight splice variant of PON2 will also be determined. It also aims to develop a protocol for determining PON2 status by examining the levels of PON2 protein, activity and mRNA in mouse and human macrophages. PON2 levels in males, and in pre- and post-menopausal women will be analyzed. Aim 4 will examine the role of PON2 in modulating susceptibility to the neurotoxicants Mn and Cd, both of which are known to induce oxidative stress. Altogether, the proposed experiments will provide novel information on the role of PON1 and PON2 in modulating oxidative stress and protecting individuals from cardiovascular and neurological diseases.

View original record on NIH RePORTER →